Press Release

Groupe Technologique KDA completes acquisition of electronic ZRx Prescriber for United States, Europe ans United Kingdom

Thetford Mines, Quebec – May 11, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that its wholly owned subsidiary, Groupe Technologique Inc. (“KDA Techno”) has completed the acquisition of the ownership rights in the ZRx Prescriber to develop, commercialize and exploit the ZRx Prescriber in the United States, Europe and the United Kingdom, in consideration for 20,000,000 Class A shares (the “KDA Shares”) of KDA’s share capital (the “Transaction”).

KDA Technologiy Group announces KRx, it’s new integrated medical management platform for dental clinics

Thetford Mines, Quebec – April 7, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) are pleased to announce the commercialization for the Canadian market of its brand new integrated medical management platform for dental clinics called KRx dental.

KDA Group announces net earnings for the second quarter of 2021 and an update on its technology projects

Thetford Mines, Quebec – March 23, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) has released its unaudited condensed consolidated financial results for the second quarter ended January 31, 2021 (“Q2-2021”). The Corporation’s financial results, together with the management’s discussion and analysis, have been filed on SEDAR. All financial figures are in Canadian dollars unless otherwise indicated.

GROUPE TECHNOLOGIQUE KDA SIGNED AN ASSET PURCHASE AGREEMENT WITH ZOOMMED MÉDICAL FOR THE ACQUISITION OF ZRX PRESCRIBER FOR DEVELOPMENT AND EXPLOITATION IN THE UNITED STATES, EUROPE AND UNITED KINGDOM

Thetford Mines, Quebec – March 10, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce, as previously disclosed in its press release dated November 18, 2020, that its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) has entered into an asset purchase and rights assignment agreement (the “Asset Purchase Agreement”) with ZoomMed Médical Inc. (“ZoomMed Médical”) under which Tech KDA agreed to acquire, subject to certain conditions, the ZRx Prescriber and ownership rights, to develop, commercialize and exploit the ZRx Prescriber in the United States, Europe and United Kingdom, in consideration for 20,000,000 Class A shares (the “KDA Shares”) of KDA’s share capital (the “Transaction”).

KDA GROUP GRANTS STOCK OPTIONS

Thetford Mines, Quebec – February 18, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that, pursuant to its stock option plan, it has granted incentive stock options to directors, officers, employees and consultants of the Corporation to purchase up to an aggregate of 7,000,000 Class A shares (the “Common shares”). 

KDA Group amends stock option plan and issues shares to two officers

Thetford Mines, Quebec – January 7, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that it has approved an amendment to its stock option plan (the ”Stock Option Plan”) in order to increase the number of class A shares (“Common Shares”) that may be issued pursuant to the exercise of options under the Stock Option Plan from 8,477,551 to 25,284,189 being 20% of the Corporation’s issued and outstanding Common Shares.

KDA Group modifies its strategic advisory board

Thetford Mines, Quebec – December 9, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the new composition of its Strategic Advisory Board (the “Strategic Board”) with the addition of Messrs. Denis Gadbois, Yves Salembier and Dr. Shane Morris.

Groupe KDA © 2019  |  Tous droits réservés